Sialic acid capping of CD8β core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction

  • Anne Marie Moody
  • , Simon J. North
  • , Bruce Reinhold
  • , Steven J. Van Dyken
  • , Mark E. Rogers
  • , Maria Panico
  • , Anne Dell
  • , Howard R. Morris
  • , Jamey D. Marth
  • , Ellis L. Reinherz

Research output: Contribution to journalArticlepeer-review

Abstract

Bidentate interaction of a T-cell receptor and CD8αβ heterodimer with a peptide-MHCI complex is required for the generation of cytotoxic T-lymphocytes. During thymic development, the modification of CD813 glycans influences major histocompatibility complex class I binding to T-cell precursors called thymocytes. ES mass spectrometry (MS) and tandem MS/MS analysis were used to identify the changes occurring in the CD8β-glycopeptides during T-cell development. Several threonine residues proximal to the CD8β Ig headpiece are glycosylated with core-type 1 O-glycans. Non-sialylated glycoforms are present in immature thymocytes but are virtually absent in mature thymocytes. These results suggest how sialylation in a discrete segment of the CD8β stalk by ST3Gal-1 sialyltransferase creates a molecular developmental switch that affects ligand binding.

Original languageEnglish
Pages (from-to)7240-7246
Number of pages7
JournalJournal of Biological Chemistry
Volume278
Issue number9
DOIs
StatePublished - Feb 28 2003

Fingerprint

Dive into the research topics of 'Sialic acid capping of CD8β core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction'. Together they form a unique fingerprint.

Cite this